Advertisement

Prolonged Survival on Hemodialysis

  • A. Peter LundinIII

Abstract

When maintenance hemodialysis (HD) began to be used to treat end-stage renal disease (ESRD) over 25 years ago, the long-term survival of the treated patients was scarcely considered, because their short-term survival seemed so chancy. Much has changed since those early days. Despite the fact that our knowledge of toxic factors and deficiencies that cause the uremic syndrome is far from complete, we see growing numbers of patients surviving on HD for 10 or more years. These long surviving hemodialysis patients (LSHP) represent one of the best successes of modern medical technology.

Keywords

Dialysis Patient Hemodialysis Patient Carpal Tunnel Syndrome Gastrin Level Renal Osteodystrophy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lundin AP, Adler AJ, Feinroth MV, Berlyne GM, Friedman EA: Maintenance hemodialysis, survival beyond the first decade. JAMA 244: 38, 1980PubMedCrossRefGoogle Scholar
  2. 2.
    Rostand SG, Kirk KA, Rutsky EA: Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease. Kidney Int 22: 304, 1982PubMedCrossRefGoogle Scholar
  3. 3.
    Charra B, Calemard E, Cuche M, Laurent G: Control of hypertension and prolonged survival on maintenance hemodialysis. Nephron 33: 96, 1983PubMedCrossRefGoogle Scholar
  4. 4.
    Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: result of phase I and II clinical trial. N Engl J Med 326: 73, 1987CrossRefGoogle Scholar
  5. 5.
    Plough AL, Salem S: Social and contextual factors in the analysis of mortality in end-stage renal disease patients. Am J Public Health 72: 1293, 1982PubMedCrossRefGoogle Scholar
  6. 6.
    Jacobs C, Broyer M, Brunner FA, Brynger H, Donckerwolcke RA, Kramer P, Selwood NH, Wing AJ: Combined report on regular transplantation in Europe XI 1980. Proc Eur Dial Transplant Assoc 18: 2, 1981Google Scholar
  7. 7.
    Gabardini FP, Surian M, Colussi G: Uremic patients under dialysis and/or transplantation for more than ten years in Italy, in: Uremia: Pathobiology of Patients Treated for 10 Years or More, edited by Giordano C, Friedman EA, Milan, Wichtig Editore, 1981, p 41Google Scholar
  8. 8.
    Blagg CR, Wahl PW, Lamers JU: Treatment of chronic renal failure at the Northwest Kidney Center, Seattle from 1960 to 1982. asaio J 6: 170, 1983Google Scholar
  9. 9.
    Shapiro F, Umen A: Risk factors in hemodialysis patient survival. asaio J 6: 176, 1983Google Scholar
  10. 10.
    Mion CM, Murad G, Canaud B, Chong G: Maintenance dialysis: A survey of 17 years’ experience in Languedoc-Roussillon with a comparison of methods in a ‘Standard Population.’ asaio J 6: 205, 1983Google Scholar
  11. 11.
    Hutchinson TA, Harvey CE: Survival with different forms of dialysis treatment, asaio J 8: 13, 1985Google Scholar
  12. 12.
    Pendras JP: Parathyroid disease in long-term maintenance hemodialysis. Arch Intern Med 124: 312, 1969PubMedCrossRefGoogle Scholar
  13. 13.
    Scribner BH: The long-term Seattle hemodialysis and transplant survivors, in: Uremia: Pathobiology of Patients Treated for 10 Years or More, edited by Giordano C, Friedman EA, Milan, Wichtig Editore, 1981, p 32Google Scholar
  14. 14.
    Haire HM, Sherrard DJ, Scardapane D, Curtis FK, Brunzell JD: Smoking, hypertension and mortality in a maintenance dialysis population. Cardiovasc Med 3: 1163, 1978Google Scholar
  15. 15.
    Bradley JR, Evans DB, Calne R: Long-term survival in hemodialysis patients. Lancet 1: 295, 1987PubMedCrossRefGoogle Scholar
  16. 16.
    Baillod RA, Varghese Z, Fernando ON, Moorhead JF: Review of 71 patients receiving renal replacement for greater than 10 years, in: Uremia: Pathobiology of Patients Treated for 10 Years or More, edited by Giordano C, Friedman EA, Milan, Wichtig Editore, 1981, p 35Google Scholar
  17. 17.
    Zingraff J, Man NK, Drüeke T, Jungers P, Crosnier J, Funck-Brentano JL: Long-term results in forty uremic patients treated by hemodialysis for more than 10 years, in: Uremia: Pathobiology of Patients Treated for 10 Years or More, edited by Giordano C, Friedman EA, Milan, Wichtig Editore, 1981, p 50Google Scholar
  18. 18.
    Abramowitz EM, Musunuru RSK, Scarpa WJ, Mandel G: Cardiovascular effects of a decade or longer of maintenance hemodialysis, in: Prevention of Kidney Disease and Long-Term Survival, edited by Avram MM, New York, Plenum, 1982, p 177Google Scholar
  19. 19.
    Lundin AP, Stein RA, Frank F, LaBelle P, Berlyne GM, Krasnow N, Friedman EA: Cardiovascular status in long-term hemodialysis patients: An exercise and echocardiographic study. Nephron 28: 234, 1981CrossRefGoogle Scholar
  20. 20.
    Brunzell JD, Albers JJ, Haas LB, Goldberg AP, Agadoa L, Sherrard DJ: Prevalence of serum lipid abnormalities in chronic hemodialysis. Metabolism 26: 903, 1977PubMedCrossRefGoogle Scholar
  21. 21.
    Bagdade JD, Subbaiah PV, Pantos D, Bartos F, Campbell RA: Polyamines: An unrecognized cardiovascular risk factor in chronic dialysis. Lancet 1: 412, 1979PubMedCrossRefGoogle Scholar
  22. 22.
    Frank WM, Rao TKS, Manis T, Delano BG, Avram MM, Saxena AK, Carter AC, Friedman EA: Relationship of plasma lipids to renal function and length of time on maintenance hemodialysis. Am J Clin Nutr 31: 1886, 1982Google Scholar
  23. 23.
    Parfitt AM: Soft tissue calcification in uremia. Arch Intern Med 124: 544, 1969PubMedCrossRefGoogle Scholar
  24. 24.
    Kuzela DL, Hoffer WE, Conger JD, Winter SD, Hammond WS: Soft tissue calcification in chronic dialysis patients. Am J Path 86: 406, 1977Google Scholar
  25. 25.
    Terman DS, Alfrey AC, Hammond WS, Donndelinger T, Ogden DA, Holmes JH: Cardiac calcification in uremia. A clinical, biochemical and pathologic study. Am J Med 50: 744, 1971PubMedCrossRefGoogle Scholar
  26. 26.
    Conger JD, Hammond WS, Alfrey AC, Contiguglia SR, Stanford RE, Huffer WE: Pulmonary calcification in chronic dialysis patients, clinical and pathologic studies. Ann Intern Med 83: 330, 1975PubMedGoogle Scholar
  27. 27.
    Brynger H, Brunner FP, Chantier C, Donckerwolke RA, Jacobs C, Kramer P, Seiwood NH, Wing AJ: Combined report on regular dialysis and transplantation in Europe X, 1979 Proc Eur Dial Transplant Assoc 17: 2, 1980PubMedGoogle Scholar
  28. 28.
    Piccoli G, Giachino G, Jeantet A, Quarello F, Bossi P, Squiccimarro G, Zatteri R, Rossi P, Vercellone A: Bone disease in hemodialyzed patients treated for 10 years or more, in: Uremia: Pathobiology of Patients Treated for 10 Years or More, edited by Giordano C, Friedman EA, Milan, Wichtig Editore, 1981, p 89Google Scholar
  29. 29.
    Lindergard B, Lindholm T, Sandstrom S, Johnell O: Renal osteodystrophy in patients dialyzed for 10 years or more, in: Uremia: Pathobiology of Patients Treated for 10 Years or More, edited by Giordano C, Friedman EA, Milan, Wichtig Editore, 1981,p 83Google Scholar
  30. 30.
    Ott SM, Andress DL, Nebeker HG, Milliner DS, Maloney NA, Coburn JW, Sherrard DJ: Changes in bone histology after treatment with desferrioxamine. Kidney Int 29 (Suppl 18): S108,1986Google Scholar
  31. 31.
    Main J, Velasco N, Catto GRD, Fräser RA, Edward N, Adami S, O’Riordan JLH: The effect of hemodialysis, vitamin D metabolits and renal osteodystrophy on the skeletal demineralization associated with renal osteodystrophy. Clin Nephrol 26: 279, 1986PubMedGoogle Scholar
  32. 32.
    Andress DL, Ott SM, Maloney NA, Sherrard DJ: Effect of parathyroidectomy on aluminum accumulation in chronic renal failure. N Engl J Med 312: 468, 1985PubMedCrossRefGoogle Scholar
  33. 33.
    Charhon SA, Berland YF, Olmer MJ, Delawari E, Traeger J, Meunier PJ: Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients. Kidney Int 27: 426, 1985PubMedCrossRefGoogle Scholar
  34. 34.
    Massry SG: Is parathyroid hormone a uremic toxin? Nephron 19: 125, 1977PubMedCrossRefGoogle Scholar
  35. 35.
    Avram MM, Pahilan A, Gan A, Rizvi SA, Slater P, Fein P, Avram R, Iancu M: Factors influencing longevity of patients over 10 years on hemodialysis treatment. Role of parathyroid hormone (PTH) and serum phosphate (P). in: Uremia: Pathobiology of Patients Treated for 10 Years or More, edited by Giordano C, Friedman EA, Milan, Wichtig Editore, 1981, p 53Google Scholar
  36. 36.
    Tatler GLV, Baillod RA, Varghese Z, Young WB, Farrow S, Wills MR, Moorhead MF: Evolution of bone disease over 10 years in 135 patients with terminal renal failure. Br Med J 4: 315, 1973PubMedCrossRefGoogle Scholar
  37. 37.
    Gelfand GF, Bienenstock H, Avram MM, Rosenblum D: Musculoskeletal abnormalities of the 10-year hemodialysis patient, in: Prevention of Kidney Disease and Long-Term Survival, edited by Avram MM, New York, Plenum, 1982, p 223Google Scholar
  38. 38.
    Scardapane D, Halter S, De Lisa JA, Sherrard DJ: Hand dysfunction due to carpal tunnel syndrome: A common sequela of dialysis. Proc Clin Dial Transplant Forum 9: 15, 1979PubMedGoogle Scholar
  39. 39.
    Schwarz A, Keller F, Seyfert S, Poll W, Molzahn M, Distler A: Carpal tunnel syndrome: a major complication in long-term hemodialysis patients. Clin Nephrol 22: 133, 1984PubMedGoogle Scholar
  40. 40.
    Morita T, Suzuki M, Kamimura A, Hirasawa Y: Amyloidosis of a possible new type in patients receiving long-term hemodialysis. Arch Pathol Lab Med 109: 1029, 1985PubMedGoogle Scholar
  41. 41.
    Feaves AZ, Emmett M, White MG, Greenway G, Michaels DB: Carpal tunnel syndrome with cystic bone lesions secondary to amyloidosis in chronic hemodialysis patients. Am J Kidney Dis 1: 130, 1986Google Scholar
  42. 42.
    Casey TT, Stone WJ, DiRaimondo CR, Brontley BD, DiRaimondo CV, Gorevic PD, Page DL: Tumoral amyloidosis of bone of beta2-microglobulin origin in association with long-term hemodialysis. Human Path 17: 731, 1986CrossRefGoogle Scholar
  43. 43.
    Brown EA, Arnold IR, Gower PE: Dialysis arthropathy: complications of long-term treatment with hemodialysis. Br Med J 292: 166, 1986CrossRefGoogle Scholar
  44. 44.
    DiPillo FW, Gandhi H: Over decade maintenance hemodialysis: Its effect on uremic anemia and coagulation, in: Prevention of Kidney Disease and Long-Term Survival, edited by Avram MM, New York, Plenum, 1982, p 191Google Scholar
  45. 45.
    Coratelli P, Corciulo R, Izzo P, Amerio A: Globin synthesis of patients on regular dialysis treatment for more than 10 years, in: Uremia: Pathobiology of Patients Treated for 10 Years or More, edited by Giordano C, Friedman EA, Milan, Wichtig Editore, 1981, p 138Google Scholar
  46. 46.
    Döbbelsteiii H: Immune system in uremia.Nephron 17: 409, 1976CrossRefGoogle Scholar
  47. 47.
    Wilson WEC, Kirkpatrick CH, Talmage DW: Suppression of immunologic responsiveness in uremia. Ann Intern Med 62: 1, 1965Google Scholar
  48. 48.
    Vercellone A, Segoloni GP, Giacchino F, Canavese C, Messina M, Pozzato M, Rotunno M, Squiccimarro G, Thea A, Camussi G, Piccoli G: Immune responsiveness versus dialytic age. in: Uremia: Pathobiology of Patients Treated for 10 Years or More, edited by Giordano C, Friedman EA, Milan, Wichtig Editore, 1981, p 273Google Scholar
  49. 49.
    Dunea G, Mahurkar SD, Mamdani B, Smith EC: Role of aluminum in dialysis dementia. Ann Intern Med 88: 502, 1978PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • A. Peter LundinIII

There are no affiliations available

Personalised recommendations